Craig E. Devoe

Craig E. Devoe

Oncology
450 Lakeville Road
Entrance B
Lake Success, NY 11042

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Addition of High-Dose Vitamin D3 to Standard Treatment in Patients With Metastatic Colorectal Cancer: The SOLARIS Randomized Clinical Trial (Alliance A021703).

Addition of High-Dose Vitamin D3 to Standard Treatment in Patients With Metastatic Colorectal Cancer: The SOLARIS Randomized Clinical Trial (Alliance A021703).

Journal: JAMA
Published: August 03, 2026

Sirexatamab in Combination with Bevacizumab and Chemotherapy as Second-Line Therapy for Advanced Colorectal Adenocarcinoma: the Phase II DeFianCe Trial.

Sirexatamab in Combination with Bevacizumab and Chemotherapy as Second-Line Therapy for Advanced Colorectal Adenocarcinoma: the Phase II DeFianCe Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 23, 2026

AKI After Hepatic Histotripsy.

AKI After Hepatic Histotripsy.

Journal: Kidney international reports
Published: March 07, 2026

Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.

Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 24, 2025

PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.

PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 10, 2025

Targeting Neutrophil Extracellular Traps to inhibit Colon Cancer Tumor Necrosis and Metastasis.

Targeting Neutrophil Extracellular Traps to inhibit Colon Cancer Tumor Necrosis and Metastasis.

Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025

Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results.

Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results.

Journal: Nature medicine
Published: April 11, 2025

Management of Peritoneal Metastasis in Patients with Pancreatic Ductal Adenocarcinoma.

Management of Peritoneal Metastasis in Patients with Pancreatic Ductal Adenocarcinoma.

Journal: Current oncology (Toronto, Ont.)
Published: January 01, 2025

Updates in the Management of Uveal Melanoma.

Updates in the Management of Uveal Melanoma.

Journal: Cancer journal (Sudbury, Mass.)
Published: March 25, 2024

Comparing gastrointestinal stromal tumor outcomes between geriatric and non-geriatric patients: A population-based analysis.

Comparing gastrointestinal stromal tumor outcomes between geriatric and non-geriatric patients: A population-based analysis.

Journal: World journal of surgery
Published: January 01, 2024

Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial.

Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial.

Journal: Nature medicine
Published: July 25, 2023

Diversifying Eligibility to Enhance Real-World Results.

Diversifying Eligibility to Enhance Real-World Results.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 12, 2023
Showing 1-12 of 36

Last Updated: 09/26/2026